Clinical Trial Update: High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-flow oxygen to reduce exertional dyspnea in cancer patients; status and results not clearly reported in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Malignant Neoplasm

Drugs mentioned

• High-flow oxygen therapy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Dyspnea, Malignant Neoplasm | Phase 2 | Status: UNKNOWN | Results posted: 2021-06-01